Maersk-Moller Kimberly 4

What Happened

• Kimberly Maersk‑Moller, Chief Commercial Officer of MiMedx Group, received two awards on 2026-03-04 totaling 136,231 shares: 74,163 shares (non-derivative) and 62,068 shares (derivative). Both awards show an acquisition price of $0.00, so no cash was paid for the grants.

Key Details

• Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (appears timely).
• Awards: 74,163 shares @ $0.00 (acquired); 62,068 shares @ $0.00 (derivative/acquired). Total awarded = 136,231 shares.
• Shares owned after transaction: Not specified in the excerpt provided.
• Footnotes from the filing:
  • F1: The restricted stock award vests fully on the third anniversary of the grant, subject to continued employment.
  • F2: Notes inclusion of 3,492 shares acquired 2026-01-30 under the company ESPP (Employee Stock Purchase Plan).
  • F3: Describes option vesting (25% each anniversary) for option grants referenced elsewhere in the filing.
• Transaction code: A (award/grant). No sale or open-market purchase reported.

Context

• This was an equity award (not a purchase or sale). Awards granted at $0.00 are common for employee compensation and typically vest over time (see F1).
• The 62,068 derivative shares are restricted/derivative shares subject to vesting conditions; they are not immediately liquid shares unless and until they vest.
• No indication here of a 10% owner transaction, sale, or cashless exercise. The filing does not show any immediate disposition of shares.